Category Archives: Opioid access

Two crises at one time: Access to opioids for patients in palliative care in times of the US opioid crisis

Posted on July 18, 2019 by pallcare

Prof Dr Christoph Ostgathe, Dr Sébastien Moine, Dr Julie Ling (European Association for Palliative Care) and Prof Lukas Radbruch (International Association for Hospice & Palliative Care). The USA ‘opioid crisis’ is a well-documented public health disaster and a human tragedy, (0) with … Continue reading →

Posted in ADVOCACY & POLICY, EAPC Board Members, Opioid access | Tagged | 1 Comment

Do you know how to access #palliativecare when you need it?

Posted on October 13, 2017 by pallcare

Continuing the Salzburg Questions series that encourages a global discussion about the key issues affecting palliative care. Today, ahead of World Hospice and Palliative Care Day tomorrow (14 October 2017), Dr Stephen Connor, Executive Director Worldwide Hospice Palliative Care Alliance … Continue reading →

Posted in ADVOCACY & POLICY, Opioid access, Salzburg Global Seminar Series | Tagged , , | Leave a comment

Project Estar ao Seu Lado: Living with total pain in Brazil

Posted on October 7, 2016 by pallcare

In this special post to celebrate World Hospice and Palliative Care Day tomorrow, Santiago Rodríguez Corrêa, a family physician, and Carla Mazuko, a nurse, from Project Estar ao Seu Lado, Brazil, pick up the theme of this year’s event: ‘Living … Continue reading →

Posted in ADVOCACY & POLICY, Opioid access | Tagged , | 2 Comments

Living and dying in pain: It doesn’t have to happen

Posted on September 28, 2016 by pallcare

  World Hospice and Palliative Care Day is a unified day of action to celebrate and support hospice and palliative care around the world. Ahead of this year’s event on 8 October, Dr Stephen R Connor, Executive Director, Worldwide Hospice … Continue reading →

Posted in ADVOCACY & POLICY, Opioid access | Tagged | Leave a comment

Opioid overdose death epidemic sensationalised at the cost of pain patients

Posted on March 2, 2016 by pallcare

Willem Scholten, PharmD MPA, Consultant – Medicines and Controlled Substances, Willem Scholten Consultancy, Lopik, the Netherlands Recently, I published an article with Jack E. Henningfield on the ‘opioid overdose death epidemic’ in which we challenged the usual view of an epidemic … Continue reading →

Posted in ADVOCACY & POLICY, Opioid access | Tagged | 4 Comments